The principal goal of the Alport Syndrome Foundation, Inc. (ASF), Pedersen Family, and the Kidney Foundation of Canada (KFOC) Funding Program is to find novel treatments to prevent kidney failure and hearing loss in all patients with Alport Syndrome.
Types of Projects Sought
Research projects with the potential to accelerate the development of new treatments to prolong kidney function and hearing loss including:
It is anticipated that two research projects will be selected for funding, totaling US $100,000 each, over a one- to two-year timeframe. Successful applicants will be notified in June 2018 in accordance with the ASF, Pedersen Family, KFOC Alport Syndrome Research Funding Program. There are no geographical limitations of this funding.
Letters of intent (LoIs) will be evaluated by an independent peer review process. LoIs should be no longer than 2 pages in length and must be in accordance with the instructions in the ASF, Pedersen Family, KFOC Alport Syndrome Research Funding Program. Authors of the LoIs found to have the best merit for funding will be invited to submit a full proposal application 10–15 pages in length for further independent peer review. Final grant recipients will be selected from this pool. The detailed schedule and instructions can be found here: Letter of Intent Guidelines
The deadline for submission of a letter of intent has passed. Successful applicants will be notified in June.
For Additional Information, go to www.alportsyndrome.org or Contact:
Gina Parziale, Executive Director, Alport Syndrome Foundation, Inc.